Practice patterns, gaps, and priorities in infection management for patients receiving bispecific antibodies and CAR-T cell therapy – Results from the E-Impact survey of the EHA-SWG infections in hematology
Bispecific antibodies (BsAbs) and chimeric antigen receptor T-cell (CAR-T) therapies have transformed the treatment of hematologic malignancies, but infectious complications remain a leading cause of morbidity and mortality. We conducted a multicenter international survey across 101 institutions—predominantly academic tertiary hospitals (80.2%)—to characterize contemporary prevention and management practices. We assessed antimicrobial prophylaxis, infection surveillance, and management of therapy-induced immunodeficiency for patients receiving BsAbs and/or CAR-T. Practices were highly heterogeneous. According to respondents’ perception, viral infections were the most frequent with BsAbs (69.3%), whereas bacterial infections predominated after CAR-T (52.8%). Anti–Pneumocystis jirovecii prophylaxis was nearly universal (93.5% BsAbs; 97.5% CAR-T), but antibacterial and antifungal prophylaxis varied widely and were omitted in 86% and 38.7% of BsAb centers, respectively. CMV monitoring strategies differed markedly; one-third of BsAb centers did not routinely monitor CMV-DNA. Most respondents identified better guidelines (72.3% BsAbs; 52.8% CAR-T), improved diagnostic tools, and multidisciplinary approaches as priorities. These findings underscore substantial practice variation and the urgent need for harmonized, evidence-based guidance, particularly in light of recent data highlighting prolonged hypogammaglobulinemia, infection burden per patient-month with continuously dosed BsAbs, and the potential protective effect of immunoglobulin replacement. Prospective studies are warranted to define optimal prophylaxis, surveillance, and immunoglobulin replacement strategies in these populations.
Authors
- Jon Salmanton-Garcia (ORCID: https://orcid.org/0000-0002-6766-8297)
- Livio Pagano (ORCID: https://orcid.org/0000-0001-8287-928X)
- Oliver A. Cornely (ORCID: https://orcid.org/0000-0001-9599-3137)
- María Stefania Infante
- Sigrun Einarsdottir (ORCID: https://orcid.org/0000-0003-4756-6805)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Cologne (DE)
- Sahlgrenska University Hospital (SE)
- Agostino Gemelli University Polyclinic (IT)
- Research Institute Hospital 12 de Octubre (ES)
- Düsseldorf University Hospital (DE)
- Hospital Universitario 12 De Octubre (ES)
- German Center for Infection Research (DE)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Annals of Hematology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s00277-026-07358-6
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Univerzita Komenského v Bratislave
- İstanbul Medeniyet Üniversitesi
- Universität Wien
- Università degli Studi di Padova
- Universidad Autónoma de Nuevo León
- Shanghai Jiao Tong University
- Università Cattolica del Sacro Cuore
- Medizinische Universität Wien
- Aristotle University of Thessaloniki
- Fakultní Nemocnice Plzen
- Università degli Studi di Torino
- Sjællands Universitetshospital
- School of Medicine, Shanghai Jiao Tong University
- National Cancer Institute
- Cliniques Universitaires Saint-Luc